Luca Crepaldi has a diverse work experience spanning multiple companies and roles. Luca began their career as an undergraduate student at the Dept. of Pathology - Sect. of General Pathology - University of Verona, Italy in 1999. Luca then pursued their PhD at Medizinische Universitaet Innsbruck, where they worked as a PhD student from 2003 to 2006. Following this, they joined University College London as a postdoc from 2006 to 2015. At the Wellcome Sanger Institute, Luca held two positions, starting as a Senior Research Assistant from 2015 to 2019, and then transitioning to a Staff Scientist role from 2019 to 2021. Currently, Luca is working for bit.bio, where they started as a Senior Scientist in July 2021 and later transitioned to a Group Leader, Discovery Screening role in November 2022.
Luca Crepaldi completed their education from 1994 to 2000 at the Università degli Studi di Verona, where they pursued a degree in Biotecnologie Agro-Industriali. Prior to that, they attended the Liceo Scientifico Galileo Galilei, located in Adria. Further details about their degree and field of study during their time at the Liceo Scientifico Galileo Galilei are not provided.
November, 2022 - present
July, 2021